Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XQJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,090
Award facts
- Contract value 100% obligated
- $12,089.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 7, 2025, for JAKAFI 20 mg tablets (60-count units) valued at $12,089.78. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the procurement of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. The award carries no set-aside designation, and the place of performance is Park Ridge, Illinois, with an ultimate completion date of August 8, 2025.
JAKAFI (ruxolitinib) is a prescription medication used to treat myelofibrosis and other myeloproliferative neoplasms, representing a specialty pharmaceutical product within DMS Pharmaceutical Group's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's robust federal contracting history demonstrates consistent success in supplying critical pharmaceutical items to military and federal healthcare systems nationwide, positioning it as a significant contributor to the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DX25F6XQJ?
SPE2DX25F6XQJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 7, 2025.
How much is contract SPE2DX25F6XQJ worth?
The government has obligated $12,090 on SPE2DX25F6XQJ.
Is contract SPE2DX25F6XQJ an order under another contract?
Yes. SPE2DX25F6XQJ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XQJ competed?
The extent of competition for SPE2DX25F6XQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award